Home / Programs /
From Guidelines to Practice: An audit of GDMT utilisation in heart failure patients.
From Guidelines to Practice: An audit of GDMT utilisation in heart failure patients.
Approved, Heart Failure
Educational Activities (EA)
90.0
Reviewing Performance (RP)
330.0
Measuring Outcomes (MO)
60.0
Brief Overview
Chronic heart failure (referred to hereafter as heart failure, HF) remains a major public health issue in Australia, placing a significant burden on both healthcare resources and patients' quality of life. With a high prevalence, rising incidence, and significant morbidity and mortality, the need for improved management of HF, particularly in terms of guideline-directed medical therapy (GDMT), is urgent. This audit seeks to address those gaps in care and encourage widespread adoption of evidence-based practices.
Program Details

Please consult Arterial Education for more information.

1.5 hours Educational Activities

Please consult Arterial Education for more information.

5.5 hours Measuring Outcomes

Please consult Arterial Education for more information.

1.0 hour Reviewing Performamnce

Program Outcome

This audit seeks to address those gaps in care and encourage widespread adoption of evidence-based practices.

By the end of this audit, participants will be able to:

· Assess the impact of morbidity, mortality, and healthcare burden associated with HF, including the high rates of hospitalisation, rehospitalisation, and the significant economic costs, emphasising the need for improved management and adherence to guidelines

· Describe the key components of GDMT for HF (including ACEIs, ARNIs, BBs, MRAs, and SGLT2Is) and discuss their proven benefits in reducing mortality and hospitalisations in patients with HFrEF and HFpEF

· Identify common barriers to the effective implementation of GDMT in clinical practice, including under-prescription, patient-related factors, and systemic challenges, and explore strategies to overcome these barriers

· Interpret the role of NT-proBNP testing to aid in diagnosing HF, particularly in non-hospital settings, and outline how these tests can enhance detection, improving diagnostic efficiency and cost-effectiveness

· Apply evidence-based guidelines for the management of HF in clinical practice, including the appropriate use of pharmacological treatments based on ejection fraction to optimise patient care and outcomes.

 

Please consult education provider for further details

Please consult education provider for further details
Core Medical Practice Values

Education provided by an approved education provider.

Education provided by an approved education provider.
Topics Covered
Addiction Medicine
---
Anaesthetics
---
Blog Category
---
Cardiology and Vascular
---
Dentistry
---
Dermatology
---
Diagnostics and Pathology
---
Ear Nose and Throat (ENT)
---
Endocrinology
---
Events
---
FAQs Section
---
Gastroenterology and Hepatology
---
General Surgery
---
Genetic
---
Geriatrician
---
Gynaecology and Obstetric
---
Haematology
---
Immunology and Allergy
---
Master
---
Nephrology
---
Neurology and Neurosurgery
---
Oncology
---
Ophthalmology
---
Orthopedics
---
Paediatric
---
Plastic and Cosmetic Surgery
---
Program Category
---
Program Type
---
Psychiatry
---
Radiology
---
Rehabilitation Medicine
---
Respiratory
---
Rheumatology
---
Sexual and Reproductive Health
---
Urological Services
---
Topic
---
Delivery Method & Format
0 Hours total Duration
Remote
Other (Please Specify)
CPD Home (Accreditor)
RACGP - Royal Australian College of General Practitioners
Suited for
Practice Nurses, Practitioners
(02) 9954 4578

Monday - Friday
8.00am - 5.00pm AEST
Closed Saturday & Sunday

Copyright © 2022 RxTro Unit Trust. All rights reserved.